Your session is about to expire
← Back to Search
Pain Control for Ankle Fracture
Study Summary
This trial is testing a new pain medication for people with broken ankles.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Would I be a good candidate for this clinical research?
"This trial is looking for 70 patients, aged 18 to 89, who have ankle fractures that meet the following criteria: Isolated Injury, Sustained a bimalleolar ankle fracture (OTA/AO type 44 A2, B2, C1, and C2 fracture) with surgery indicated and an approach with medial and lateral incisions planned. Syndesmotic injuries will be included due to the practical difficulty of reliably determining the presence of a syndesmotic injury preoperatively. Trimalleolar ankle fractures where fixation of the posterior malleolus is not planned will also be included."
What is the governmental organization's opinion on Long-Acting Local Anesthesia?
"Long-Acting Local Anesthesia received a score of 3 because Phase 4 trials are conducted after the treatment has been approved."
Are there opportunities for patients to enroll in this trial?
"Yes, the latest information from clinicaltrials.gov suggests that this trial is still open for recruitment. The study was first posted on January 1st 2020 and was last updated on August 18th 2022. They are looking to enroll a total of 70 patients across 3 sites."
Does this research allow people who are over 45 years old to participate?
"This study includes all patients aged 18-89, as specified in the eligibility requirements."
Share this study with friends
Copy Link
Messenger